Intensive Care Weaning (iCareWean) protocol on weaning from mechanical ventilation: a single-blinded multicentre randomised control trial comparing an open-loop decision support system and routine care, in the general intensive care unit.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
02 09 2020
Historique:
entrez: 4 9 2020
pubmed: 4 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

Automated systems for ventilator management to date have been either fully heuristic rule-based systems or based on a combination of simple physiological models and rules. These have been shown to reduce the duration of mechanical ventilation in simple to wean patients. At present, there are no published studies that evaluate the effect of systems that use detailed physiological descriptions of the individual patient.The BEACON Caresystem is a model-based decision support system that uses mathematical models of patients' physiology in combination with models of clinical preferences to provide advice on appropriate ventilator settings. An individual physiological description may be particularly advantageous in selecting the appropriate therapy for a complex, heterogeneous, intensive care unit (ICU) patient population. Intenive Care weaning (iCareWean) is a single-blinded, multicentre, prospective randomised control trial evaluating management of mechanical ventilation as directed by the BEACON Caresystem compared with that of current care, in the general intensive care setting. The trial will enrol 274 participants across multiple London National Health Service ICUs. The trial will use a primary outcome of duration of mechanical ventilation until successful extubation. Safety oversight will be under the direction of an independent committee of the study sponsor. Study approval was obtained from the regional ethics committee of the Health Research Authority (HRA), (Research Ethic Committee (REC) reference: 17/LO/0887. Integrated Research Application System (IRAS) reference: 226610. Results will be disseminated through international critical care conference/symposium and publication in peer-reviewed journal. ClinicalTrials.gov under NCT03249623. This research is registered with the National Institute for Health Research under CPMS ID: 34831.

Identifiants

pubmed: 32878764
pii: bmjopen-2020-042145
doi: 10.1136/bmjopen-2020-042145
pmc: PMC7470506
doi:

Banques de données

ClinicalTrials.gov
['NCT03249623']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e042145

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: SR and DSK are minor shareholders of Mermaid Care A/S who manufacture the Beacon Caresystem. They have also acted as consultants for Mermaid Care A/S. SR is an unpaid board member of Mermaid Care A/S.

Références

J Crit Care. 2018 Dec;48:407-413
pubmed: 30317049
Med Eng Phys. 2011 Mar;33(2):240-8
pubmed: 21050794
J Clin Monit Comput. 2006 Dec;20(6):421-9
pubmed: 16977430
Intensive Care Med. 2010 Dec;36(12):2117-24
pubmed: 20689931
Anesthesiology. 2009 Oct;111(4):863-70
pubmed: 19741490
J Appl Physiol (1985). 2006 Sep;101(3):826-32
pubmed: 16763097
Med Biol Eng Comput. 2012 Jan;50(1):43-51
pubmed: 22105216
J Crit Care. 2010 Sep;25(3):367-74
pubmed: 20149586
Am J Respir Crit Care Med. 2006 Oct 15;174(8):894-900
pubmed: 16840741
BMJ Open. 2017 May 10;7(5):e014742
pubmed: 28495814
Crit Care. 2007;11(6):R118
pubmed: 17988390
J Crit Care. 2013 Aug;28(4):433-41
pubmed: 23265291
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Eur Respir J. 2007 May;29(5):1033-56
pubmed: 17470624
Biomed Tech (Berl). 2017 Apr 1;62(2):183-198
pubmed: 27930361
Comput Methods Programs Biomed. 2008 Nov;92(2):205-12
pubmed: 18715670
Cochrane Database Syst Rev. 2014 Jun 10;(6):CD009235
pubmed: 24915581
Crit Care Med. 2018 Jul;46(7):e642-e648
pubmed: 29629989
J Clin Monit Comput. 2002 Jan;17(1):43-52
pubmed: 12102249
BMJ. 2011 Jan 13;342:c7237
pubmed: 21233157
Mayo Clin Proc. 2017 Sep;92(9):1382-1400
pubmed: 28870355

Auteurs

M P Vizcaychipi (MP)

APMIC, Imperial College London, London, UK m.vizcaychipi@imperial.ac.uk.
Magill Department of Anaesthesia and Intensive Care Medicine, Chelsea and Westminster Healthcare NHS Trust, London, UK.

Laura Martins (L)

Research Trial Unit, Chelsea and Westminster Hospital NHS Foundation Trust, London, London, UK.

James R White (JR)

Magill Department of Anaesthesia, Chelsea and Westminster Hospital NHS Foundation Trust, London, London, UK.

Dan Stleper Karbing (DS)

Center for Model-based Medical Decision Support, Aalborg Universitet, Aalborg, Denmark.

Amandeep Gupta (A)

Anaesthetic Department, West Middlesex University Hospital NHS Trust, London, London, UK.

Suveer Singh (S)

Magill Department of Anaesthesia and Intensive Care Medicine, Chelsea and Westminster Healthcare NHS Trust, London, UK.

Leyla Osman (L)

Magill Department of Anaesthesia, Chelsea and Westminster Hospital NHS Foundation Trust, London, London, UK.

Jeronimo Moreno-Cuesta (J)

Anaesthetic Department, North Middlesex University Hospital NHS Trust, London, London, UK.

Steve Rees (S)

Department of Health Science and Technology, Aalborg Universitet Institut for Medicin og Sundhedsteknologi, Aalborg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH